Alzheimer's disease (AD) is characterized by Amyloid, Tau, and Neurofilament chain (NfL: a newer biomarker of neurodegeneration) pathology (ATN), which summarizes neural injury and accumulation of amyloid and tau plaques in the brain. Here, MAPT is linked to oculocutaneous albinism type 1.